Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880679 · ClinicalTrials.gov registry record · NA
Ultrasound Acute Chest Syndrome Sickle Cell Disease
A NA study of Sickle Cell Disease and Acute Chest Syndrome, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06880679 is a NA study of Sickle Cell Disease and Acute Chest Syndrome that is actively recruiting participants, run by Indiana University. The registered enrollment target is 30 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06880679, a NA study of Sickle Cell Disease and Acute Chest Syndrome, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Conditions Studied
Interventions
- DEVICE Point of Care Ultrasound
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06880679
The ClinicalTrials.gov registry entry for NCT06880679 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Point of Care Ultrasound is the first listed.
NCT06880679 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06880679 about?
NCT06880679 is a clinical study titled "Ultrasound Acute Chest Syndrome Sickle Cell Disease". Feasibility and reliability of ultrasound in the inpatient hematology setting.
What is the current status of trial NCT06880679?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-08. Estimated completion is 2026-03-01.
What conditions does trial NCT06880679 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Acute Chest Syndrome.
What interventions are being tested in trial NCT06880679?
The interventions under investigation include: Point of Care Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06880679?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880679 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.